The proposed framework provides a flexible and interpretable approach to treatment effect inference under distributional heterogeneity and achieves a favorable balance between robustness and statistical efficiency.
Abstract
Longitudinal continuous outcomes in clinical trials are commonly analyzed using mixed models for repeated measures (MMRM) under normality assumptions. However, many clinical outcomes are skewed, making mean-based treatment effects difficult to interpret and potentially reducing statistical efficiency. The Box--Cox MMRM (BCMMRM) approach accommodates skewness by enabling inference on model-based median differences via inverse transformation. However, BCMMRM typically assumes a common transformation parameter across treatment groups and time points. When distributional shapes differ between groups or evolve over time, this assumption may lead to biased treatment effect. Furthermore, when treatment affects not only central tendency but also distributional shape or tail behavior, treatment effects may not be adequately characterized by a single location summary such as the median. We propose the Box--Cox multivariate regression (BCMVR) framework for longitudinal data with skewed outcomes. BCMVR relaxes this restriction by allowing transformation parameters to vary across groups and time points. The framework enables inference based on interpretable summaries, including median differences and a probability-based treatment effect quantifying the probability that a randomly selected patient in one group has a better outcome than one in another group. This measure integrates information over the entire outcome distribution and provides a complementary summary when distributional shapes differ. Simulation studies demonstrate that BCMMRM can produce biased estimates when distributions differ in shape, whereas BCMVR provides nearly unbiased estimation. The probability-based measure achieves a favorable balance between robustness and statistical efficiency. The proposed framework provides a flexible and interpretable approach to treatment effect inference under distributional heterogeneity.
A new inference method for conducting multiple-treatment comparisons involving endpoints within the generalized linear model (GLM) framework under covariate-adaptive randomization (CAR) that can effectively control Type I error while potentially improving power.
Multivariate endpoints are increasingly used in clinical studies on rare diseases, where sample sizes tend to be small and distributional assumptions are often violated. In such settings, commonly applied parametric multivariate methods, such as classical MANOVA approaches, may suffer from inflated type‐I error or redu...
Martin Geroldinger, M. Laimer, V. Wally et al.· Statistics in Medicine· 0 citations
This work develops the nonparametric efficiency theory and derive the efficient influence function for the cumulative incidence of an event under a DTR in the presence of a competing risk and right-censoring and proposes a sequentially doubly robust estimator that accommodates flexible machine learning for nuisance est...
Nitya Shah, Laura D. Carbone, Howard A. Fink et al.· 0 citations
Biomedical studies often collect mixed-type longitudinal data (e.g., clinical, lifestyle) to identify predictors of a binary health outcome. A common analytical challenge is to link these irregularly collected variables to the outcome, particularly when the number of potential predictors is large. While joint models (J...
Lingpeng Shan, Michelle J. Naughton, E. Paskett et al.· Statistical Methods in Medic...· 0 citations
The Weighted Spline-Expanded Network (WSENet), an end-to-end neural framework that addresses causal effects with continuous treatments in observational studies by combining covariate balancing, structured treatment embedding, and bias-corrected outcome estimation, is proposed.
Shu-Cheng Liu, Chan Park, Guan-Hua Chen· 0 citations
The log-rank test and Kaplan--Meier plot are standard tools for analyzing time-to-event data in randomized clinical trials, yet neither provides a summary of the magnitude of the treatment effect. Practitioners typically fill this gap by reporting a hazard ratio from a Cox proportional-hazards model or an acceleration...
Lucy D'Agostino McGowan, Joseph Rigdon, Xin-Ran Li et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.